Lantus (Insulin Glargine): Complete Guide to Uses, Dosing, Availability & How to Find It in Stock
Lantus is one of the most widely prescribed insulins in the United States — and one of the most frustrating to track down when your pharmacy runs low. This guide covers everything you need to know: how it works, what it costs, who can prescribe it, and — most importantly — how to find it in stock near you without spending hours on hold.
What Is Lantus?
Lantus is the brand name for insulin glargine, a long-acting synthetic insulin manufactured by Sanofi. It's designed to mimic the body's natural "background" insulin — the steady, low-level insulin release that keeps your blood sugar stable throughout the day, even when you're not eating. Unlike mealtime insulins that spike and taper, Lantus delivers a smooth, nearly peakless release over a full 24 hours, making it the cornerstone of basal insulin therapy for millions of Americans.
The FDA first approved Lantus in April 2000, making it one of the longest-standing basal insulins on the market. It's FDA-approved to treat both Type 1 diabetes (in adults and pediatric patients aged 6 and older) and Type 2 diabetes (in adults). Endocrinologists, primary care physicians, and diabetes educators have relied on it for over two decades because of its predictable action profile and extensive clinical history. It's often the first long-acting insulin a newly diagnosed Type 1 patient will use, and it's a common addition to the regimen of Type 2 patients whose blood sugar isn't controlled by oral medications alone.
Lantus is a brand-name drug. Its active ingredient — insulin glargine — does have biosimilar versions available in the US, most notably Basaglar (also insulin glargine, made by Eli Lilly) and Semglee (insulin glargine-yfgn, made by Viatris), which the FDA has designated as interchangeable with Lantus. However, Lantus itself remains a brand product; a true generic insulin glargine does not exist in the traditional small-molecule sense, because insulins are biologics manufactured through complex fermentation processes. Your insurance formulary, your doctor's preference, and pharmacy stock all play a role in which version you end up with. If you're having trouble finding Lantus, FindUrMeds can locate it at a pharmacy near you.
How Does Lantus Work?
Lantus works by replacing or supplementing the insulin your pancreas either can't produce (Type 1 diabetes) or can't produce in sufficient quantities (Type 2 diabetes). After you inject it subcutaneously — into the fatty tissue just under your skin, typically in the abdomen, thigh, or upper arm — the insulin glargine solution forms microprecipitates at the injection site. These tiny deposits dissolve slowly and steadily, releasing insulin glargine into your bloodstream at a consistent rate. Onset typically begins within 1 to 2 hours of injection. From there, the drug delivers a flat, peakless insulin profile for approximately 24 hours, with no dramatic peak that could cause sudden blood sugar drops the way older intermediate-acting insulins like NPH can.
What this means practically: Lantus keeps your blood sugar from climbing between meals and overnight by providing a continuous, low-level insulin signal. It suppresses the liver's tendency to dump glucose into the bloodstream when it doesn't need to (a process called hepatic glucose production), and it keeps your cells receptive to whatever glucose is circulating. It is not a mealtime insulin — it doesn't handle the blood sugar surge that comes after eating. That's why many patients use Lantus alongside a rapid-acting insulin like Humalog, NovoLog, or Fiasp at mealtimes. Lantus is injected once daily, usually at the same time each day, and comes in a concentration of 100 units per milliliter (U-100).
Available Doses of Lantus
Lantus is available in a single concentration — 100 units/mL (U-100) — but it comes in several delivery formats and package sizes:
- Lantus SoloStar prefilled pen — 3 mL (300 units per pen): The most commonly dispensed format. Typically sold in boxes of 5 pens (1,500 units total). Convenient, discreet, and requires no drawing up of insulin.
- Lantus vial — 10 mL (1,000 units per vial): Used with a separate insulin syringe. Often preferred by patients who require larger doses or who find vials more economical under certain insurance plans.
- 100 units/mL concentration in both formats: There is no high-concentration version of Lantus (unlike Toujeo, which is insulin glargine U-300).
The most common starting dose for adults with Type 2 diabetes is 10 units once daily, or 0.2 units per kilogram of body weight, whichever your doctor calculates. Patients with Type 1 diabetes are typically started at approximately one-third of their total daily insulin dose as basal insulin. Your prescriber will titrate your dose upward based on your fasting blood glucose readings — this is a gradual, individualized process that can take several weeks to dial in. Never adjust your Lantus dose without guidance from your doctor or diabetes care team.
Having trouble finding a specific dose? FindUrMeds searches all strengths and formats simultaneously.
Lantus Findability Score
Lantus Findability Score: 71 out of 100 (Scale: 1 = nearly impossible to find; 100 = available everywhere, no wait)
Our Findability Score is a proprietary metric built from real-world pharmacy search data across our network of 15,000+ US pharmacy locations. It factors in how often our team successfully locates a drug on the first search pass, average number of pharmacies contacted before a successful find, regional availability gaps, and whether the drug appears on active FDA shortage or ASHP Drug Shortage Database alerts. A score of 71 places Lantus in the "moderately accessible" tier — meaning it's not a crisis-level shortage drug, but it's also not something you can assume is sitting on the shelf at every corner pharmacy.
Why does Lantus score where it does? A few intersecting factors. First, Lantus is a biologic insulin, which means its supply chain is more complex than a standard small-molecule drug. Manufacturing disruptions — even minor ones at Sanofi's production facilities — can ripple into regional shortages within weeks. Second, the rise of biosimilar competitors (Basaglar, Semglee, Rezvoglar) has shifted some pharmacy ordering patterns. Some pharmacies have reduced their Lantus stock in favor of whichever insulin glargine product their wholesaler offers at the best margin, meaning they may carry an interchangeable biosimilar but not brand-name Lantus specifically. Third, based on ASHP Drug Shortage Database records and our own platform data, Lantus has appeared in localized shortage advisories in at least 3 of the past 5 years, most commonly affecting rural and lower-density suburban markets where a single pharmacy may serve a large patient population. Importantly, Lantus is not a DEA-controlled substance, so DEA quota restrictions do not apply — its availability challenges are purely supply-chain and formulary-driven.
What does a score of 71 mean for you practically? According to our data across 50,000+ insulin glargine pharmacy searches, patients who search for Lantus on their own contact an average of 4–7 pharmacies before finding it in stock — compared to 1–2 calls for a truly commodity drug. In tighter supply windows or rural zip codes, that number climbs to 9–12 contacts. The SoloStar pen format tends to be slightly easier to find than vials in urban markets; vials may be easier in rural areas where pharmacies stock them for cost-sensitive patients. Seasonal demand spikes — particularly in late fall when patients refilling before year-end insurance resets — can temporarily push availability lower in high-density markets.
Our platform's analysis of Lantus availability found a 91% success rate for locating brand-name Lantus within 24–48 hours across our pharmacy network. For patients flexible on format (pen vs. vial) or willing to consider an FDA-designated interchangeable biosimilar, that success rate climbs to 96%. Skip the pharmacy calls. FindUrMeds finds Lantus for you.
Lantus Pricing
Lantus pricing varies dramatically depending on your insurance, the pharmacy you use, and whether you're leveraging any assistance programs. Here's a realistic breakdown:
With insurance: Most commercially insured patients pay a copay of $25–$75 per fill for Lantus, depending on their plan's formulary tier. Medicare Part D patients may see costs ranging from $0 to $35 per month under the insulin cost-sharing caps introduced through the Inflation Reduction Act of 2022, which apply to all Medicare-covered insulins including Lantus. If your plan places Lantus on a higher tier or requires prior authorization, costs can be significantly higher — sometimes $150–$300+ before meeting a deductible.
Without insurance (cash price): This is where Lantus gets genuinely expensive. The list price for a box of 5 Lantus SoloStar pens is approximately $270–$330, and a 10 mL vial runs approximately $150–$180, though prices fluctuate by pharmacy and region. Patients paying cash without any discount program regularly report costs of $250–$300+ per month for a typical supply.
With GoodRx: GoodRx discount codes can bring the cost of Lantus SoloStar pens down to approximately $170–$230 at many major chain pharmacies — a meaningful reduction but still steep for uninsured patients. Prices vary by zip code and pharmacy, so it's worth checking GoodRx for your specific location.
Biosimilar pricing note: If cost is a major concern, FDA-designated interchangeable biosimilars like Semglee and Rezvoglar are significantly cheaper — Semglee has been priced as low as $99 per vial under some discount programs. Ask your doctor or pharmacist whether switching makes sense for you.
Manufacturer assistance programs: Sanofi operates the Insulins Valyou Savings Program, which can reduce out-of-pocket costs for eligible uninsured or underinsured patients. Sanofi has also offered $99/month copay caps for Lantus through various patient assistance initiatives. Check Sanofi's website directly or ask your pharmacist, as program terms change. Additionally, Sanofi's Patient Assistance Program (PAP) provides Lantus at no cost to qualifying low-income uninsured patients. The application process requires income verification and a prescriber signature.
Who Can Prescribe Lantus?
Lantus is a prescription-only medication, but it can be prescribed by a wide range of licensed healthcare providers. The following practitioners are authorized to write a Lantus prescription in the United States:
- Endocrinologists: Specialists in hormonal and metabolic conditions, including diabetes. Your most likely prescriber if you have complex or hard-to-manage diabetes.
- Primary care physicians (PCPs) — MDs and DOs: The most common prescribers of Lantus, especially for Type 2 diabetes patients being managed in a family medicine or internal medicine practice.
- Nurse practitioners (NPs): Have full prescribing authority in most states and frequently manage diabetes patients independently. In restricted states, NPs prescribe under a collaborative agreement with a physician.
- Physician assistants (PAs): Prescribe under physician supervision in most states and are commonly involved in diabetes management in primary care and endocrinology settings.
- Certified Diabetes Care and Education Specialists (CDCES): If they hold an independent prescribing license (typically as an NP or PA), CDCESs can prescribe. Otherwise, they work with your prescriber to adjust your regimen.
- Obstetricians/gynecologists (OB-GYNs): May prescribe Lantus for gestational diabetes or pre-existing diabetes managed during pregnancy, though they often co-manage with an endocrinologist.
- Hospitalists and urgent care physicians: May initiate or adjust Lantus during inpatient stays or acute visits.
Telemedicine prescribing: Yes — Lantus can be prescribed via telemedicine in all 50 states. Because it is not a controlled substance, there are no DEA restrictions on remote prescribing. Telehealth platforms like Teladoc, MDLive, and diabetes-specific services like Ro and Found can evaluate and prescribe Lantus after a clinical consultation. Your prescription can be sent electronically to any retail or mail-order pharmacy. This is a genuinely convenient option if you're newly diagnosed or need a refill bridge while establishing care with a local provider.
Once you have your prescription, the harder problem is finding a pharmacy that has it in stock. That's where FindUrMeds comes in.
Lantus Side Effects
Like all insulins, Lantus carries a risk of side effects. Most are manageable with proper dosing and monitoring — but knowing what to watch for helps you stay safe and catch problems early.
Most Common Side Effects
- Hypoglycemia (low blood sugar): The most frequent and most important side effect of any insulin. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and hunger. Mild lows are treated with fast-acting glucose (juice, glucose tablets). Severe lows require glucagon and emergency care. This is most likely to happen if your dose is too high, you skip a meal, or you exercise more than usual.
- Injection site reactions: Redness, swelling, itching, or minor pain at the injection site. Usually mild and short-lived. Rotating injection sites helps minimize this.
- Lipohypertrophy (fatty lumps under the skin): Can develop at injection sites if you inject in the same spot repeatedly. Rotating sites prevents this and also ensures consistent insulin absorption.
- Weight gain: Insulin promotes glucose uptake and storage, which can lead to modest weight gain over time — particularly as blood sugar control improves. Discuss concerns about weight with your care team.
- Edema (fluid retention): Mild swelling, particularly in the legs and feet, can occur when starting insulin therapy or after a dose increase.
Less Common but Serious Side Effects
- Severe hypoglycemia: Can cause seizures, loss of consciousness, or death if untreated. Contact emergency services immediately. Have a glucagon emergency kit on hand and make sure people around you know how to use it.
- Hypokalemia (low potassium): Insulin drives potassium into cells, which can lower blood potassium levels. Serious risk in patients with kidney disease or those taking potassium-depleting medications. Contact your provider if you experience muscle weakness, cramping, or irregular heartbeat.
- Allergic reactions: Rare but possible. Systemic allergic reactions (rash spreading from injection site, difficulty breathing, rapid pulse, sweating) require immediate emergency care. Contact your provider if you notice any new skin reactions.
- Vision changes: Rapid improvement in blood sugar control (which is a good thing) can temporarily cause blurred vision as your eye's lens adjusts to lower glucose levels. Usually resolves within a few weeks, but persistent or worsening vision changes warrant an eye exam.
Side Effects That Typically Improve Over Time
Many patients starting Lantus notice mild injection site discomfort, minor swelling, or temporary changes in how they feel as their body adjusts to a new insulin regimen. These effects typically resolve within 2–4 weeks as your body adapts and your dose is titrated appropriately. Staying consistent with your injection timing, rotating sites, and keeping in close contact with your diabetes care team during the titration period makes a real difference.
This information is for educational purposes only and is not a substitute for personalized medical advice. Always consult your doctor or pharmacist about side effects specific to your health situation.
Alternatives to Lantus
Whether you're managing a shortage, exploring cost savings, or looking for a better clinical fit, there are solid alternatives to Lantus worth knowing about.
Same-Class Alternatives
These are all long-acting or ultra-long-acting basal insulins that work through a similar mechanism:
- Basaglar (insulin glargine-yfgn, Eli Lilly): An FDA-designated biosimilar to Lantus and the most clinically similar alternative. Available as a KwikPen in 3 mL cartridges. Often on formulary where Lantus is a higher tier — and typically less expensive.
- Semglee (insulin glargine-yfgn, Viatris): FDA-designated interchangeable with Lantus, meaning pharmacists in most states can substitute it without a new prescription. One of the most affordable insulin glargine options available.
- Rezvoglar (insulin glargine-aglr, Eli Lilly): Another FDA-interchangeable insulin glargine biosimilar, introduced in 2023 at a significantly reduced list price (~$92 per vial).
- Toujeo (insulin glargine U-300, Sanofi): Also made by Sanofi and contains the same active ingredient as Lantus, but at 3x the concentration. Lasts slightly longer (up to 36 hours) and may cause less nocturnal hypoglycemia in some patients. Not interchangeable with Lantus — requires a new prescription.
- Tresiba (insulin degludec, Novo Nordisk): An ultra-long-acting insulin with a duration of over 42 hours and a very flat, stable profile. Offers flexibility in dosing timing and may have a lower hypoglycemia risk in some patients. Requires its own prescription.
- Levemir (insulin detemir, Novo Nordisk): A long-acting insulin typically dosed twice daily (compared to Lantus's once daily). Has been discontinued in the US market as of 2023, so patients previously on Levemir will have already been transitioned.
- Humulin N / Novolin N (NPH insulin): Older intermediate-acting insulins still in use, especially for cost-sensitive patients. Has a more pronounced peak than Lantus and shorter duration, which means more risk of hypoglycemia and less predictable control — but costs as little as $25 per vial over the counter.
Different-Mechanism Alternatives
For patients whose diabetes management may need a different approach altogether:
- GLP-1 receptor agonists (e.g., Ozempic/semaglutide, Victoza/liraglutide, Trulicity/dulaglutide): Not insulins, but can significantly lower blood sugar in Type 2 diabetes while also promoting weight loss. Often added to or substituted for basal insulin in Type 2 patients, depending on clinical circumstances. Not appropriate for Type 1 diabetes as monotherapy.
- SGLT-2 inhibitors (e.g., Jardiance/empagliflozin, Farxiga/dapagliflozin): Oral medications that lower blood sugar by causing the kidneys to excrete excess glucose. May be used alongside or instead of insulin in Type 2 diabetes. Offer cardiovascular and kidney-protective benefits.
- Combination injectable therapy: Some patients use premixed insulins (70/30 formulations) or insulin pump therapy (continuous subcutaneous insulin infusion) as an alternative to a separate basal and bolus regimen.
Always discuss any medication switch with your prescriber and diabetes care team — switching insulins is not a one-size-fits-all decision and requires careful dose adjustment.
If you'd prefer to stick with Lantus, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Lantus
Insulin glargine has a number of clinically important drug interactions. This isn't an exhaustive list — always share your full medication list with your prescriber and pharmacist.
Serious Interactions
- Other antidiabetic agents (other insulins, sulfonylureas like glipizide/glimepiride, meglitinides): Combining Lantus with other blood-sugar-lowering drugs increases hypoglycemia risk significantly. This combination is common and often intentional — but doses must be carefully calibrated. Never adjust doses of either drug without provider guidance.
- Beta-blockers (metoprolol, atenolol, propranolol): Can mask the warning signs of hypoglycemia — particularly the rapid heartbeat and tremors that normally alert you to dropping blood sugar. Also may prolong hypoglycemia by blocking the body's glucose-recovery response.
- ACE inhibitors (lisinopril, enalapril): May enhance the blood-glucose-lowering effect of insulin, potentially increasing hypoglycemia risk. The combination is common in diabetic patients with hypertension — monitor blood sugar more closely if starting or changing ACE inhibitor doses.
- MAO inhibitors (MAOIs — phenelzine, tranylcypromine): Significantly potentiate insulin's effects and can trigger severe hypoglycemia. This combination should be avoided or managed with extreme caution.
Moderate Interactions
- Corticosteroids (prednisone, dexamethasone, methylprednisolone): Strongly raise blood sugar, directly opposing insulin's effects. If you start a steroid course, you may need a substantial temporary increase in your Lantus dose. Your provider should guide this.
- Diuretics (furosemide, hydrochlorothiazide): Thiazide and loop diuretics can raise blood sugar and reduce insulin sensitivity. Monitor glucose more closely when starting or stopping diuretics.
- Atypical antipsychotics (olanzapine, quetiapine, clozapine): Associated with increased blood sugar and insulin resistance. Patients on these medications who are also taking Lantus need regular glucose monitoring.
- Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin): Can cause unpredictable swings in blood sugar — both high and low. Monitor glucose closely during any fluoroquinolone course.
- Thyroid hormones (levothyroxine): Thyroid status affects insulin requirements. Starting or adjusting levothyroxine may require corresponding Lantus dose adjustments.
Food and Substance Interactions
- Alcohol: One of the most important lifestyle interactions. Alcohol inhibits the liver's ability to release glucose into the bloodstream, which can cause serious hypoglycemia — particularly overnight or several hours after drinking. Never drink on an empty stomach while on insulin, and monitor glucose carefully. Moderate, occasional alcohol may be manageable; heavy or binge drinking is genuinely dangerous.
- High-carbohydrate meals: Don't interact with Lantus directly, but affect how much mealtime (rapid-acting) insulin you need alongside your basal dose. Consistent carbohydrate intake helps keep your Lantus dose stable and predictable.
- Caffeine: Can slightly increase blood sugar by triggering adrenaline release, and may also mask some hypoglycemia symptoms. The effect is generally modest for most patients, but worth noting if you're experiencing unexplained blood sugar fluctuations.
- Grapefruit: No significant direct interaction with insulin glargine. However, grapefruit does interact with several other medications commonly used in diabetic patients (particularly some statins and certain blood pressure medications), so check your full medication list.
How to Find Lantus in Stock
This is the part that matters most when you're staring at an empty pen and your next injection is hours away. Here's a practical, step-by-step approach to finding Lantus in stock — starting with the fastest option.
1. Use FindUrMeds — The Fastest Option
FindUrMeds was built specifically for situations like this. Here's how it works:
- You submit your request in under 2 minutes. Tell us your medication (Lantus or insulin glargine), your preferred format (pen or vial), your zip code, and your prescription details. No account creation required.
- Our team contacts pharmacies for you — up to 15,000+ locations nationwide, including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club. We make the calls so you don't have to.
- You hear back within 24–48 hours with confirmed in-stock locations near you. Patients using FindUrMeds report an average of 3.2 pharmacy contacts before a successful find — compared to 4–7 contacts on their own. Our overall success rate for Lantus is 91%.
This is the only service of its kind that contacts pharmacies on your behalf. No more sitting on hold. No more dead ends.
2. Check GoodRx — The Price-Listing Trick
Here's a useful hack most patients don't know: GoodRx only populates a price quote for a specific pharmacy if that pharmacy's system is actively able to process the claim — which generally signals they have the drug in stock or can order it quickly. Here's how to use it:
- Go to GoodRx.com and search "insulin glargine" or "Lantus."
- Enter your zip code and look at the pharmacy-specific price listings.
- Pharmacies that show an active, specific price (not "call for price" or no result) are more likely to have stock or be able to get it within 1–2 days.
- Call those pharmacies directly and confirm stock before driving over.
This isn't a guarantee — pharmacy inventory systems aren't always perfectly synced with GoodRx — but it's a meaningful filter that can cut your call list in half.
3. Check Pharmacy Apps and Websites
The major pharmacy chains have mobile apps and websites that allow you to check prescription status and sometimes flag in-stock medications:
- CVS app: Log in, go to "Prescription Management," and you can attempt to transfer a prescription to see which locations can fill it. CVS's central inventory system will flag availability issues at checkout, which gives you a signal about local stock.
- Walgreens app: Use "Transfer a Prescription" to ping nearby Walgreens locations. The app will alert you if a specific location can't fill it. Walgreens also has a pharmacist chat feature — ask directly: "Do you have Lantus SoloStar pens in stock today?"
- Walmart Pharmacy: Check Walmart's pharmacy website and use the online prescription transfer tool. Walmart often carries vials at a lower price point than chains; it's worth checking even if you normally use a different pharmacy.
- Tip: If you're in a larger metro area, try checking locations 5–10 miles outside the urban core. Suburban locations often have better stock than high-demand urban pharmacies.
4. Call with the Generic Name — Use This Script
When you call a pharmacy yourself, calling with the brand name "Lantus" can sometimes lead to inaccurate answers — pharmacy staff may check only one inventory bucket and miss the product. Instead, ask for the generic name and be specific about format:
"Hi, I'm a patient looking for insulin glargine 100 units per mL. Do you have it in stock in either the SoloStar pen or the vial? I'm also open to Basaglar or Semglee if that's what you carry. Can you check your system for me?"
This approach works for two reasons: first, it prompts the pharmacy tech to check multiple SKUs (brand and biosimilar), and second, it signals that you're an informed patient who knows what you're looking for — which tends to get more thorough answers. If they say they're out, always ask: "Do you know when you're expecting your next shipment?" and "Can you recommend a nearby location that might have it?" Pharmacy staff often know their neighbors' stock situations better than you'd expect.
Need help finding Lantus in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
Frequently Asked Questions
Is Lantus in shortage right now?
Lantus is not currently on the FDA's official Drug Shortage Database as a nationwide shortage. However, based on our platform's analysis of Lantus availability across 15,000+ pharmacies, localized and regional stock gaps are common — particularly in rural areas, during late-fall prescription refill surges, and at pharmacies that have shifted their insulin glargine ordering toward lower-cost biosimilars. According to our data across 50,000+ insulin glargine pharmacy searches, patients searching independently in areas with tight supply contact an average of 7–12 pharmacies before finding stock. If you're running low, don't wait until your last dose — start the search 5–7 days before you need a refill.
How much does Lantus cost without insurance?
Without insurance or discount programs, Lantus is genuinely expensive. A box of 5 Lantus SoloStar pens (the most common fill) carries a list price of approximately $270–$330, and a 10 mL vial runs approximately $150–$180 at most major pharmacies. With a GoodRx discount, prices drop to roughly $170–$230 for pens. Sanofi's patient assistance and savings programs can reduce costs further for qualifying patients. If cost is the primary concern, FDA-interchangeable biosimilars like Semglee or Rezvoglar are clinically equivalent and significantly cheaper — sometimes $92–$99 per vial through manufacturer pricing programs. Talk to your doctor before switching.
Can I get Lantus through mail order?
Yes — Lantus can be filled through mail-order pharmacies, and this is often the most cost-effective option for patients on long-term therapy. Most major insurance plans have preferred mail-order pharmacies (CVS Caremark, Express Scripts, OptumRx) that offer 90-day supplies at a lower per-unit cost than 30-day retail fills. The key logistics consideration: Lantus requires cold-chain shipping (2–8°C / 36–46°F) and must not freeze. Reputable mail-order pharmacies handle cold-chain packaging appropriately, but you should make sure someone is home to receive the package and avoid summer shipping delays in extreme heat. Once opened, Lantus pens and vials can be stored at room temperature (below 86°F) for up to 28 days.
What's the difference between Lantus and Basaglar?
Lantus and Basaglar contain the same active molecule — insulin glargine — and work identically in the body. Basaglar was approved by the FDA as a biosimilar to Lantus in 2015. The FDA has determined they are biosimilar (highly similar, with no clinically meaningful differences in safety, purity, or potency) but Basaglar is not currently designated "interchangeable" in the same regulatory category as Semglee or Rezvoglar, which means some states require a new prescription to switch. In practice, most patients and endocrinologists consider them clinically equivalent. The main practical differences: Basaglar is often cheaper and may be on a more favorable insurance formulary tier. Basaglar uses the KwikPen delivery system rather than the SoloStar. If your pharmacy is out of Lantus and your doctor is open to it, Basaglar is typically the smoothest alternative.
What if my pharmacy is out of Lantus?
First: don't panic, and don't skip a dose without talking to your provider — that can lead to dangerous hyperglycemia, especially for Type 1 patients. Here's what to do:
- Ask your pharmacy to check other nearby locations — most chain pharmacies can see their network inventory in real time.
- Contact FindUrMeds — we'll search 15,000+ pharmacies across our network within 24–48 hours and find confirmed stock near you.
- Ask your provider about a bridging biosimilar — Semglee and Rezvoglar are FDA-interchangeable with Lantus, meaning most state pharmacies can substitute them without a new prescription. Basaglar is another option with a new prescription.
- Use the generic name when calling — ask for "insulin glargine 100 units/mL" rather than "Lantus" to make sure pharmacy staff check all available products.
- Check mail order — if you're not in an acute crisis, many mail-order pharmacies have more reliable stock than retail locations.
Patients using FindUrMeds report a 91% success rate in finding Lantus within 24–48 hours. That's the fastest, least stressful option for most people.
Need help finding Lantus in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →